Methamphetamine use in the United States: Epidemiological update and implications for prevention, treatment, and harm reduction
Open accessAbstract
Recent attention has focused on the growing role of psychostimulants, such as methamphetamine in overdose deaths. Methamphetamine is an addictive and potent stimulant, and its use is associated with a range of physical and mental health harms, overdose, and mortality. Adding to the complexity of this resurgent methamphetamine threat is the reality that the increases in methamphetamine availability and harms are occurring in the midst of and intertwined with the ongoing opioid overdose crisis. Opioid involvement in psychostimulant‐involved overdose deaths increased from 34.5% of overdose deaths in 2010 to 53.5% in 2019—an increase of more than 50%. This latest evolution of the nation's overdose epidemic poses novel challenges for prevention, treatment, and harm reduction. This narrative review synthesizes what is known about changing patterns of methamphetamine use with and without opioids in the United States, other characteristics associated with methamphetamine use, the contributions of the changing illicit drug supply to use patterns and overdose risk, motivations for couse of methamphetamine and opioids, and awareness of exposure to opioids via the illicit methamphetamine supply. Finally, the review summarizes illustrative community and health system strategies and research opportunities to advance prevention, treatment, and harm reduction policies, programs, and practices.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Methamphetamine use is another growing global public health concern.
“Likewise, methamphetamine use is another growing global public health concern.(Jones et al., 2022; Paulus & Stewart, 2020)”
From A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders (2024) · cites this paper as Jones et al., 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Miech, R., Johnston, L. A., O'Malley, P., Bachman, J., Schulenberg, J., & Patrick, M. E. (2005) · doi:10.3998/2027.42/146530 · Cited by 1,771 · see citing works
Drug Overdose Deaths in the United States, 1999–2020
Hedegaard, H., Miniño, A., Spencer, M. R., & Warner, M. (2021) · doi:10.15620/cdc:112340 · Cited by 1,283 · see citing works
Mattson, C. L., Tanz, L. J., Quinn, K., Kariisa, M., Patel, P., & Davis, N. L. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7006a4 · Cited by 1,068 · see citing works
Peer-Delivered Recovery Support Services for Addictions in the United States: A Systematic Review
Bassuk, E. L., Hanson, J., Greene, R. N., Richard, M. K., & Laudet, A. B. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2016.01.003 · Cited by 559 · see citing works
(2002) · PubMed Central · Cited by 522 · see citing works
Mitchell, O., Wilson, D. B., Eggers, A., et al. (2011) · Journal of Criminal Justice · doi:10.1016/j.jcrimjus.2011.11.009 · Cited by 450 · see citing works
The need for speed: an update on methamphetamine addiction
Barr, A. M., Panenka, W. J., MacEwan, G. W., Thornton, A. E., Lang, D. J., Honer, W. G., & Lecomte, T. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0635 · Cited by 442 · see citing works
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults
Han, B., Compton, W. M., Jones, C. M., Einstein, E. B., & Volkow, N. D. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.2588 · Cited by 380 · see citing works
Self-citationLappan, S. N., Brown, A. W., & Hendricks, P. S. (2020) · Addiction · doi:10.1111/add.14793 · Cited by 370 · see citing works
Twin epidemics: The surging rise of methamphetamine use in chronic opioid users
Ellis, M. S., Kasper, Z. A., & Cicero, T. J. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.08.029 · Cited by 356 · see citing works
Ashok, A. H., Mizuno, Y., Volkow, N. D., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0135 · Cited by 330 · see citing works
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder: A Review
Paulus, M. P., & Stewart, J. L. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.0246 · Cited by 310 · see citing works
Benefits of peer support groups in the treatment of addiction
Tracy, K., & Wallace, S. (2016) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s81535 · Cited by 308 · see citing works
Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis
Cicero, T. J., Ellis, M. S., & Kasper, Z. A. (2019) · American Journal of Public Health · doi:10.2105/ajph.2019.305412 · Cited by 286 · see citing works
Crescenzo, F. D., Ciabattini, M., D’Alò, G. L., Giorgi, R. D., Giovane, C. D., Cassar, C., Janiri, L., Clark, N. C., Ostacher, M. J., & Cipriani, A. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002715 · Cited by 283 · see citing works
What is chemsex and why does it matter?
McCall, H., Adams, N., Mason, D., et al. (2015) · BMJ · doi:10.1136/bmj.h5790 · Cited by 265 · see citing works
Jones, C. M., Clayton, H. B., Deputy, N. P., Roehler, D. R., Ko, J. Y., Esser, M. B., Brookmeyer, K. A., & Hertz, M. F. (2020) · MMWR Supplements · doi:10.15585/mmwr.su6901a5 · Cited by 253 · see citing works
Self-citationLister, J. J., Weaver, A., Ellis, J. D., Himle, J. A., & Ledgerwood, D. M. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1694536 · Cited by 253 · see citing works
Patterns and Characteristics of Methamphetamine Use Among Adults — United States, 2015–2018
Jones, C. M., Compton, W. M., & Mustaquim, D. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6912a1 · Cited by 246 · see citing works
Self-citationO’Donnell, J. K., Gladden, R. M., Mattson, C. L., Hunter, C. T., & Davis, N. L. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6935a1 · Cited by 246 · see citing works
Sexualised drug use in the United Kingdom (UK): A review of the literature
Edmundson, C., Heinsbroek, E., Glass, R., Hope, V. D., Mohammed, H. P., White, M., & Desai, M. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.02.002 · Cited by 242 · see citing works
Strathdee, S. A., & Stockman, J. K. (2010) · Current HIV/AIDS Reports · doi:10.1007/s11904-010-0043-7 · Cited by 241 · see citing works
Treatment of stimulant use disorder: A systematic review of reviews
Ronsley, C., Nolan, S., Knight, R., Hayashi, K., Klimas, J., Walley, A., Wood, E., & Fairbairn, N. (2020) · PLOS ONE · doi:10.1371/journal.pone.0234809 · Cited by 222 · see citing works
Methamphetamine: Effects on the brain, gut and immune system
Prakash, M. D., Tangalakis, K., Antonipillai, J., Stojanovska, L., Nurgali, K., & Apostolopoulos, V. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.009 · Cited by 220 · see citing works
Substance-Use Outcomes at 18 Months Past Baseline
Spoth, R. L., Redmond, C. R., Shin, C., Greenberg, M. T., Clair, S., & Feinberg, M. E. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.01.014 · Cited by 203 · see citing works
Heroin and Methamphetamine Injection: An Emerging Drug Use Pattern
Al-Tayyib, A., Koester, S., Langegger, S., & Raville, L. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2016.1271432 · Cited by 203 · see citing works
Contingency management for the treatment of methamphetamine use disorder: A systematic review
Brown, H. D., & DeFulio, A. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108307 · Cited by 171 · see citing works
Gilbart, V. L., Simms, I., Jenkins, C., Furegato, M., Gobin, M., Oliver, I., Hart, G., Gill, O. N., & Hughes, G. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052014 · Cited by 170 · see citing works
Crystalline methamphetamine use and methamphetamine‐related harms in Australia
Degenhardt, L., Sara, G., McKetin, R., Roxburgh, A., Dobbins, T., Farrell, M., Burns, L., & Hall, W. D. (2017) · Drug and Alcohol Review · doi:10.1111/dar.12426 · Cited by 159 · see citing works
Seattle’s Law Enforcement Assisted Diversion (LEAD): Program effects on recidivism outcomes
Collins, S. E., Lonczak, H. S., & Clifasefi, S. L. (2017) · Evaluation and Program Planning · doi:10.1016/j.evalprogplan.2017.05.008 · Cited by 151 · see citing works
Hoots, B., Vivolo-Kantor, A. M., & Seth, P. (2020) · Addiction · doi:10.1111/add.14878 · Cited by 150 · see citing works
Self-citationInnovation During COVID-19: Improving Addiction Treatment Access
Samuels, E. A., Clark, S. A., Wunsch, C., Keeler, L. A. J., Reddy, N. G., Vanjani, R., & Wightman, R. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000685 · Cited by 143 · see citing works
Increases in methamphetamine use among heroin treatment admissions in the United States, 2008–17
Jones, C. M., Underwood, N., & Compton, W. M. (2020) · Addiction · doi:10.1111/add.14812 · Cited by 142 · see citing works
Self-citationMethamphetamine Overdose Deaths in the US by Sex and Race and Ethnicity
Han, B., Cotto, J., Etz, K., Einstein, E. B., Compton, W. M., & Volkow, N. D. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.4321 · Cited by 140 · see citing works
Self-citationAmlani, A., McKee, G., Khamis, N., Raghukumar, G., Tsang, E., & Buxton, J. A. (2015) · Harm Reduction Journal · doi:10.1186/s12954-015-0088-4 · Cited by 134 · see citing works
Strickland, J. C., Havens, J. R., & Stoops, W. W. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107592 · Cited by 133 · see citing works
Park, J. N., Rashidi, E., Foti, K., Zoorob, M., Sherman, S., & Alexander, G. C. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108416 · Cited by 128 · see citing works
Darke, S. G., Kaye, S. S., & Duflou, J. A. (2017) · Addiction · doi:10.1111/add.13897 · Cited by 125 · see citing works
Shearer, R. D., Howell, B. A., Bart, G. B., & Winkelman, T. N. A. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108162 · Cited by 124 · see citing works
Mahoney, J. J., Hanlon, C. A., Marshalek, P. J., Rezai, A. R., & Krinke, L. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117149 · Cited by 121 · see citing works
Resurgent Methamphetamine Use at Treatment Admission in the United States, 2008–2017
Jones, C. M., Olsen, E. O., O’Donnell, J. K., & Mustaquim, D. (2020) · American Journal of Public Health · doi:10.2105/ajph.2019.305527 · Cited by 115 · see citing works
Self-citationLong-term Effects of Universal Preventive Interventions on Methamphetamine Use Among Adolescents
Spoth, R. L., Clair, S., Shin, C., & Redmond, C. R. (2006) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.160.9.876 · Cited by 112 · see citing works
Nationwide dissemination of contingency management: The veterans administration initiative
Petry, N. M., DePhilippis, D., Rash, C. J., Drapkin, M. L., & McKay, J. R. (2014) · American Journal on Addictions · doi:10.1111/j.1521-0391.2014.12092.x · Cited by 110 · see citing works
Criminal justice continuum for opioid users at risk of overdose
Brinkley‐Rubinstein, L., Zaller, N. D., Martino, S., Cloud, D. H., McCauley, E., Heise, A., & Seal, D. W. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.02.024 · Cited by 109 · see citing works
Ginley, M. K., Pfund, R. A., Rash, C. J., & Zajac, K. (2021) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000552 · Cited by 108 · see citing works
Drug Overdose Deaths in the United States, 1999-2019.
Hedegaard, H. B., Miniño, A., & Warner, M. (2020) · PubMed · Cited by 101 · see citing works
A scoping review of post opioid-overdose interventions
Bagley, S. M., Schoenberger, S. F., Waye, K. M., & Walley, A. Y. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105813 · Cited by 101 · see citing works
Prevalence and nature of cardiovascular disease in methamphetamine-related death: A national study
Darke, S. G., Duflou, J. A., & Kaye, S. S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.07.001 · Cited by 100 · see citing works
Tsui, J. I., Mayfield, J., Speaker, E. C., Yakup, S., Ries, R. K., Funai, H., Leroux, B. G., & Merrill, J. O. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.10.005 · Cited by 100 · see citing works
Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington
Glick, S. N., Burt, R. D., Kummer, K., Tinsley, J., Banta‐Green, C. J., & Golden, M. R. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.10.011 · Cited by 99 · see citing works
Compton, W. M., Jones, C. M., Baldwin, G. T., Harding, F. M., Blanco, C., & Wargo, E. M. (2019) · American Journal of Public Health · doi:10.2105/ajph.2019.305020 · Cited by 98 · see citing works
Self-citationTelehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019
Lin, L. A., Fernandez, A. C., & Bonar, E. E. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.1698 · Cited by 97 · see citing works
Díaz, R. M. (2005) · Journal of Urban Health · doi:10.1093/jurban/jti026 · Cited by 95 · see citing works
Contingency management treatments: controversies and challenges
Petry, N. M. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02879.x · Cited by 94 · see citing works
Jones, C. M. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.04.006 · Cited by 94 · see citing works
Self-citationTheories of Addiction: Methamphetamine Users' Explanations for Continuing Drug Use and Relapse
Newton, T. F., Garza, R. D. L., Kalechstein, A. D., Tziortzis, D., & Jacobsen, C. A. (2009) · American Journal on Addictions · doi:10.1080/10550490902925920 · Cited by 93 · see citing works
Formica, S. W., Apsler, R., Wilkins, L. E., Ruiz, S., Reilly, B., & Walley, A. Y. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.01.001 · Cited by 93 · see citing works
DePhilippis, D., Petry, N. M., Bonn‐Miller, M. O., Rosenbach, S. B., & McKay, J. R. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.12.020 · Cited by 91 · see citing works
Carlson, R. G., Daniulaityte, R., Silverstein, S. M., Nahhas, R. W., & Martins, S. S. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102722 · Cited by 90 · see citing works
Pharmacological treatments for methamphetamine addiction: current status and future directions
Ballester, J., Valentine, G. W., & Sofuoglu, M. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1268916 · Cited by 89 · see citing works
Spoth, R. L., Redmond, C. R., Shin, C., Greenberg, M. T., Feinberg, M. E., & Trudeau, L. (2017) · Psychological Medicine · doi:10.1017/s0033291717000691 · Cited by 82 · see citing works
Glick, S. N., Klein, K. S., Tinsley, J., & Golden, M. R. (2020) · American Journal on Addictions · doi:10.1111/ajad.13115 · Cited by 81 · see citing works
Substance Use among Men Who Have Sex with Men
Compton, W. M., & Jones, C. M. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2033007 · Cited by 80 · see citing works
Self-citationLopez, A. M., Dhatt, Z. K., Howe, M., Al-Nassir, M., Billing, A. S., Artigiani, E., & Wish, E. D. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.103098 · Cited by 79 · see citing works
A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis
Voce, A., Calabria, B., Burns, R. A., Castle, D. J., & McKetin, R. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2018.1521430 · Cited by 75 · see citing works
Daniulaityte, R., Silverstein, S. M., Crawford, T. N., Martins, S. S., Zule, W. A., Zaragoza, A. J., & Carlson, R. G. (2020) · Substance Use & Misuse · doi:10.1080/10826084.2020.1765805 · Cited by 71 · see citing works
An evolving problem: Methamphetamine production and trafficking in the United States
Shukla, R. K., Crump, J. L., & Chrisco, E. S. (2012) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2012.07.004 · Cited by 68 · see citing works
Trends in characteristics of individuals who use methamphetamine in the United States, 2015-2018
Palamar, J. J., Han, B. H., & Keyes, K. M. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108089 · Cited by 67 · see citing works
Self-citationCo-involvement of Opioids in Drug Overdose Deaths Involving Cocaine and Psychostimulants
Hedegaard, H. B. (2021) · doi:10.15620/cdc:103966 · Cited by 65 · see citing works
Known fentanyl use among clients of harm reduction sites in British Columbia, Canada
Karamouzian, M., Papamihali, K., Graham, B. M., Crabtree, A., Mill, C., Kuo, M. E., Young, S., & Buxton, J. A. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102665 · Cited by 62 · see citing works
Schiff, D. M., Drainoni, M., Weinstein, Z., Chan, L., Bair‐Merritt, M. H., & Rosenbloom, D. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.09.003 · Cited by 61 · see citing works
Mellis, A. M., Potenza, M. N., & Hulsey, J. N. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108180 · Cited by 61 · see citing works
Baker, R., Leichtling, G. J., Hildebran, C., Pinela, C., Waddell, E. N., Sidlow, C., Leahy, J. M., & Korthuis, P. T. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000669 · Cited by 58 · see citing works
The continued rise of methamphetamine use among people who use heroin in the United States
Strickland, J. C., Stoops, W. W., Dunn, K. E., Smith, K. E., & Havens, J. R. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108750 · Cited by 56 · see citing works
DARK Classics in Chemical Neuroscience: Methamphetamine
Abbruscato, T. J., & Trippier, P. C. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00123 · Cited by 55 · see citing works
Adolescent Opioid Misuse Attributable to Adverse Childhood Experiences
Swedo, E. A., Sumner, S. A., de Fijter, S., Werhan, L., Norris, K., Beauregard, J. L., Montgomery, M. P., Rose, E. B., Hillis, S. D., & Massetti, G. M. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.05.001 · Cited by 55 · see citing works
Trends in Methamphetamine Use Among Men Who Have Sex with Men in New York City, 2004–2017
Rivera, A. V., Harriman, G., Carrillo, S. A., & Braunstein, S. (2020) · AIDS and Behavior · doi:10.1007/s10461-020-03097-5 · Cited by 55 · see citing works
Maxwell, J. C. (2013) · Substance Use & Misuse · doi:10.3109/10826084.2013.841244 · Cited by 51 · see citing works
Outreach to people who survive opioid overdose: Linkage and retention in treatment
Langabeer, J. R., Champagne‐Langabeer, T., Luber, S., et al. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.12.008 · Cited by 51 · see citing works
Howell, B. A., Bart, G. B., Wang, E. A., & Winkelman, T. N. A. (2020) · Medical Care · doi:10.1097/mlr.0000000000001460 · Cited by 48 · see citing works
Development of a Statewide, Publicly Accessible Drug Overdose Surveillance and Information System
Marshall, B. D. L., Yedinak, J. L., Goyer, J., et al. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.304007 · Cited by 43 · see citing works
Vivolo-Kantor, A. M., Hoots, B., Seth, P., & Jones, C. M. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108323 · Cited by 43 · see citing works
Self-citationShifts in drug seizures in the United States during the COVID-19 pandemic
Palamar, J. J., Le, A., Carr, T. H., et al. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108580 · Cited by 42 · see citing works
Pattern and related factors of cognitive impairment among chronic methamphetamine users
Wang, T., Fan, T., Bao, Y., Li, X.-D., Liang, C., Wang, R., Ma, J., Han, Y., Meng, S., Wu, P., et al. (2017) · American Journal on Addictions · doi:10.1111/ajad.12505 · Cited by 39 · see citing works
National Drug Threat Assessment 2006
(2006) · PsycEXTRA Dataset · doi:10.1037/e568962006-001 · Cited by 39 · see citing works
Yatsco, A. J., Champagne‐Langabeer, T., Holder, T. F., Stotts, A. L., & Langabeer, J. R. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102849 · Cited by 39 · see citing works
Fletcher, J. B., Swendeman, D. T., & Reback, C. J. (2018) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1447173 · Cited by 38 · see citing works
Silverstein, S. M., Daniulaityte, R., Getz, K., & Zule, W. A. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1949612 · Cited by 38 · see citing works
To Battle The Opioid Overdose Epidemic, Deploy The ‘Cascade Of Care’ Model
Williams, A. R., Nunes, E. V., & Olfson, M. (2017) · doi:10.7916/d8rx9qf3 · Cited by 37 · see citing works
Cunningham, E. B., Jacka, B. P., DeBeck, K., Applegate, T. L., Harrigan, P. R., Krajden, M., Marshall, B. D. L., Montaner, J. S. G., Lima, V. D., Olmstead, A. D., et al. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.04.005 · Cited by 35 · see citing works
Cheng, W. S., Garfein, R. S., Semple, S. J., Strathdee, S. A., Zians, J. K., & Patterson, T. L. (2010) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2010.10399781 · Cited by 32 · see citing works
Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use
Stevens, M. W., Stevens, M. W., Stevens, M. W., Stevens, M. W., Tawney, R., Tawney, R., Tawney, R., Tawney, R. L., West, C. M., West, C. M., et al. (2013) · mAbs · doi:10.4161/mabs.27620 · Cited by 32 · see citing works
Methamphetamine exposures reported to United States poison control centers, 2000–2019
Chen, T., Spiller, H. A., Badeti, J., Funk, A. R., Zhu, M., & Smith, G. A. (2021) · Clinical Toxicology · doi:10.1080/15563650.2020.1861287 · Cited by 29 · see citing works
Immunotherapy for treating methamphetamine, heroin and cocaine use disorders
Xiaoshan, T., Junjie, Y., Wenqing, W., Zeng, Y., Jiaping, L., Shanshan, L., Nandakumar, K. S., & Kui, C. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.07.009 · Cited by 28 · see citing works
Lessons from Scott County — Progress or Paralysis on Harm Reduction?
Kishore, S., Hayden, M. C., & Rich, J. D. (2019) · New England Journal of Medicine · doi:10.1056/nejmp1901276 · Cited by 26 · see citing works
Vaccine development against methamphetamine drug addiction
Hossain, M. K., Hassanzadeganroudsari, M., Nurgali, K., & Apostolopoulos, V. (2020) · Expert Review of Vaccines · doi:10.1080/14760584.2020.1857738 · Cited by 23 · see citing works
McMahan, V., Kingston, S., Newman, A., Stekler, J. D., Glick, S. N., & Banta‐Green, C. J. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108243 · Cited by 18 · see citing works
Local Overdose Fatality Review Team Recommendations for Overdose Death Prevention
Haas, E. E., Truong, C., Bartolomei-Hill, L., Baier, M., Bazron, B., & Rebbert‐Franklin, K. (2018) · Health Promotion Practice · doi:10.1177/1524839918797617 · Cited by 17 · see citing works
A Public Health Guide to Ending the Opioid Epidemic
(2019) · Oxford University Press eBooks · doi:10.1093/oso/9780190056810.001.0001 · Cited by 10 · see citing works
Human Garbage and Physical Garbage: A Sociological Case Example of Institutional Violence
Ben‐Yehuda, N., & Einstein, S. (1984) · International Journal of the Addictions · doi:10.3109/10826088409055814 · Cited by 7 · see citing works
Flagged first, then by citations
Research works printed but not linked: 7
- [17]Han B, Cotto J, Etz K, 2021. Methamphetamine overdose deaths in the U.S. by sex and race and ethnicity. JAMA Psychiatry 7895: 564– 567. PMC8100861 33471025
- [23]Canadian Centre on Substance Use and Addiction. 2019. Canadian Community Epidemiology Network on Drug Use Bulletin: changes in stimulant use and related harms: focus on methamphetamine and cocaine. Accessed April 16, 2021. https://www.ccsa.ca/sites/default/files/2019-05/CCSA-CCENDU-Stimulant-Use-Related-Harms-Bulletin-2019-en.pdf.
- [31]Center for Behavioral Health Statistics and Quality. 2020. Results from the 2019 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration. 39437027
- [75]Bureau of Justice Assistance. Overdose fatality review data system guidance version 1.0. 2020. Accessed May 7, 2021. https://www.cossapresources.org/Content/Documents/Articles/OFR_Data_System_Guidance_Oct_2020.pdf.
- [108]McMahan WM, Kingston S, Newman A, Stekler JD, 2020. Interest in reducing methamphetamine and opioid use among syringe services program participants in Washington State. Drug Alcohol Depend. 216: 108243. 32911134 PMC9632690
- [125]Jones CM, Compton WM & Mustaquim D. 2020. Patterns and characteristics of methamphetamine use among adults – United States, 2015–2018. Morb. Mortal. Wkly. Rep 69: 317– 323. PMC7725509 32214077
- [126]Jones CM, Olsen EO, O’Donnell J, 2020. Resurgent methamphetamine use at treatment admission in the United States, 2008–2017. Am. J. Public Health 110: 509– 516. 32078347 PMC7067087
Cited by
Sorted by citations
Ivsins, A., Bonn, M., McNeil, R., Boyd, J., & Kerr, T. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.111275 · Cited by 22 · see citing works
Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder
Brett, J., Knock, E., Korthuis, P. T., Liknaitzky, P., Murnane, K. S., Nicholas, C. R., Patterson, J. C., & Stauffer, C. S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1123424 · Cited by 16 · see citing works
Nardi, W. R., Kelly, P., Roy, A., Becker, S., Brewer, J., & Sun, S. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209442 · Cited by 11 · see citing works
- Authors
- Jones, C. M., Houry, D., Han, B., Baldwin, G., Vivolo‐Kantor, A., & Compton, W. M.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institutes of Health (US)
- Division of Overdose Prevention, National Center for Injury Prevention and Control Centers for Disease Control and Prevention Atlanta Georgia
- Corresponding author
- Jones, Christopher M.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2021-09-24
- Volume
- 1508
- Issue
- 1
- Pages
- 3-22
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- PMC
- PMC9097961
- OpenAlex
- W3199254314
- Cited by
- 202
- References
- 100
- Citations by year
- 2026: 45 · 2025: 48 · 2024: 57 · 2023: 33 · 2022: 18
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of the New York Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CC999999)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- methamphetamine, psychostimulants, opioid overdose, polydrug use, illicit drug supply, drug use patterns, harm reduction, substance use prevention, addiction treatment, causes of drug use, United States
- MeSH terms
- Opioid Epidemic, Humans, Methamphetamine, Illicit Drugs, United States, Harm Reduction, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review